Barak, V., Goike, H., Panaretakis, K.W., and Einarsson, R. (2004). Clinical utility of cytokeratins as tumor markers. Clinical biochemistry 37, 529-540.
Bian, Z., Jin, L., Zhang, J., Yin, Y., Quan, C., Hu, Y., Feng, Y., Liu, H., Fei, B., and Mao, Y. (2016). LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Scientific reports 6, 1-12.
Bo, H., Fan, L., Li, J., Liu, Z., Zhang, S., Shi, L., Guo, C., Li, X., Liao, Q., and Zhang, W. (2018). High expression of lncRNA AFAP1-AS1 promotes the progression of colon cancer and predicts poor prognosis. Journal of Cancer 9, 4677.
Bo, H., Gong, Z., Zhang, W., Li, X., Zeng, Y., Liao, Q., Chen, P., Shi, L., Lian, Y., and Jing, Y. (2015). Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget 6, 20404.
Bradley, P.J. (2019). Symptoms and signs, staging and co-morbidity of hypopharyngeal cancer. Hypopharyngeal Cancer 83, 15-26.
Chakravarty, D., Sboner, A., Nair, S.S., Giannopoulou, E., Li, R., Hennig, S., Mosquera, J.M., Pauwels, J., Park, K., and Kossai, M. (2014). The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nature communications 5, 1-16.
Chen, S., and Shen, X. (2020). Long noncoding RNAs: functions and mechanisms in colon cancer. Molecular cancer 19, 1-13.
Cheng, J., Wang, L., Wang, H., Tang, F., Cai, W., Sethi, G., Xin, H., and Ma, Z. (2019). Insights into biological role of LncRNAs in epithelial-mesenchymal transition. Cells 8, 1178.
Chu, P.Y., Chang, S.Y., Huang, J.L., and Tai, S.K. (2010). Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx. American journal of otolaryngology 31, 168-174.
Cossu, A.M., Mosca, L., Zappavigna, S., Misso, G., Bocchetti, M., De Micco, F., Quagliuolo, L., Porcelli, M., Caraglia, M., and Boccellino, M. (2019). Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours. International journal of molecular sciences 20, 3444.
De Craene, B., and Berx, G. (2013). Regulatory networks defining EMT during cancer initiation and progression. Nature Reviews Cancer 13, 97-110.
Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., and Knowles, D.G. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome research 22, 1775-1789.
Dhamija, S., and Diederichs, S. (2016). From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis. International journal of cancer 139, 269-280.
Dongre, A., and Weinberg, R.A. (2019). New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nature reviews Molecular cell biology 20, 69-84.
Dragomir, M., Chen, B., and Calin, G.A. (2018). Exosomal lncRNAs as new players in cell-to-cell communication. Translational cancer research 7, S243.
Evdokimova, V., Tognon, C., Ng, T., and Sorensen, P.H. (2009). Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1. Cell cycle 8, 2901-2906.
Fang, Z., Zhao, J., Xie, W., Sun, Q., Wang, H., and Qiao, B. (2017). LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR‐184 expression. Cancer medicine 6, 2897-2908.
Fu, W.M., Lu, Y., Hu, B., Liang, W., Zhu, X., Yang, H., Li, G., and Zhang, J. (2016). Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways. Oncotarget 7, 4712.
Garay, T., Juhász, É., Molnár, E., Eisenbauer, M., Czirók, A., Dekan, B., László, V., Hoda, M.A., Döme, B., and Tímár, J. (2013). Cell migration or cytokinesis and proliferation?–revisiting the “go or grow” hypothesis in cancer cells in vitro. Experimental cell research 319, 3094-3103.
Garneau, J.C., Bakst, R.L., and Miles, B.A. (2018). Hypopharyngeal cancer: a state of the art review. Oral oncology 86, 244-250.
Ghafouri Fard, S., and Taheri, M. (2019). UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers. Biomedicine and Pharmacotherapy 120, 109459.
Godlewski, J., Nowicki, M.O., Bronisz, A., Nuovo, G., Palatini, J., De Lay, M., Van Brocklyn, J., Ostrowski, M.C., Chiocca, E.A., and Lawler, S.E. (2010). MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Molecular cell 37, 620-632.
Gu, Y., Chen, T., Li, G., Yu, X., Lu, Y., Wang, H., and Teng, L. (2015). LncRNAs: emerging biomarkers in gastric cancer. Future oncology 11, 2427-2441.
Gudenas, B.L., and Wang, L. (2018). Prediction of LncRNA subcellular localization with deep learning from sequence features. Scientific reports 8, 1-10.
Gutschner, T., and Diederichs, S. (2012). The hallmarks of cancer: a long non-coding RNA point of view. RNA biology 9, 703-719.
Guttman, M., and Rinn, J.L. (2012). Modular regulatory principles of large non-coding RNAs. Nature 482, 339-346.
Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. cell 144, 646-674.
Hao, N., He, Y., Li, X., Wang, K., and Wang, R. (2017). The role of miRNA and lncRNA in gastric cancer. Oncotarget 8, 81572.
Hatzikirou, H., Basanta, D., Simon, M., Schaller, K., and Deutsch, A. (2012). ‘Go or grow’: the key to the emergence of invasion in tumour progression? Mathematical medicine and biology: a journal of the IMA 29, 49-65.
Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., and Dummer, R. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer research 68, 650-656.
Huang, J., Guo, Y., Zhao, C., Yuan, S., Wang, Y., Tang, G., Zhou, W., and Sun, S. (2013). Hepatitis B virus X protein (HBx)‐related long noncoding RNA (lncRNA) down‐regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 57, 1882-1892.
Jiao, C., Song, Z., Chen, J., Zhong, J., Cai, W., Tian, S., Chen, S., Yi, Y., and Xiao, Y. (2016). lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer. Oncology reports 36, 2960-2966.
Jolly, M.K., Boareto, M., Huang, B., Jia, D., Lu, M., Ben-Jacob, E., Onuchic, J.N., and Levine, H. (2015). Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Frontiers in oncology 5, 155.
Kathagen, A., Schulte, A., Balcke, G., Phillips, H.S., Martens, T., Matschke, J., Günther, H.S., Soriano, R., Modrusan, Z., and Sandmann, T. (2013). Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells. Acta neuropathologica 126, 763-780.
Kung, J.T., Colognori, D., and Lee, J.T. (2013). Long noncoding RNAs: past, present, and future. Genetics 193, 651-669.
Lamouille, S., Xu, J., and Derynck, R. (2014). Molecular mechanisms of epithelial–mesenchymal transition. Nature reviews Molecular cell biology 15, 178-196.
Li, J., Cui, Z., Li, H., Lv, X., Gao, M., Yang, Z., Bi, Y., Zhang, Z., Wang, S., and Zhou, B. (2018a). Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis. Cancer cell international 18, 1-12.
Li, Y., Wan, Q., Wang, W., Mai, L., Sha, L., Mashrah, M., Lin, Z., and Pan, C. (2019). LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis. Biomedicine and Pharmacotherapy 112, 108719.
Li, Z., Zhu, Q., Zhang, H., Hu, Y., Wang, G., and Zhu, Y. (2018b). MALAT1: a potential biomarker in cancer. Cancer management and research 10, 6757.
Liang, H., Yu, T., Han, Y., Jiang, H., Wang, C., You, T., Zhao, X., Shan, H., Yang, R., and Yang, L. (2018). LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Molecular cancer 17, 1-13.
Liang, W.-C., Fu, W.-M., Wong, C.-W., Wang, Y., Wang, W.-M., Hu, G.-X., Zhang, L., Xiao, L.-J., Wan, D.C.-C., and Zhang, J.-F. (2015). The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 6, 22513.
Liu, Y., Sharma, S., and Watabe, K. (2015). Roles of lncRNA in breast cancer. Frontiers in bioscience (Scholar edition) 7, 94.
Luo, X., Qiu, Y., Jiang, Y., Chen, F., Jiang, L., Zhou, Y., Dan, H., Zeng, X., Lei, Y.L., and Chen, Q. (2018). Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms. Molecular cancer 17, 1-16.
Lv, J., Guo, Y., Yan, L., Lu, Y., Liu, D., and Niu, J. (2020). Development and validation of a five‐lncRNA signature with prognostic value in colon cancer. Journal of cellular biochemistry 121, 3780-3793.
Ma, M., Xu, H., Liu, G., Wu, J., Li, C., Wang, X., Zhang, S., Xu, H., Ju, S., and Cheng, W. (2019). Metabolism‐induced tumor activator 1 (MITA1), an Energy Stress–Inducible Long Noncoding RNA, Promotes Hepatocellular Carcinoma Metastasis. Hepatology 70, 215-230.
Martin, T.A., Ye, L., Sanders, A.J., Lane, J., and Jiang, W.G. (2013). Cancer invasion and metastasis: molecular and cellular perspective. In Madame Curie Bioscience Database [Internet] (Landes Bioscience).
Mas-Ponte, D., Carlevaro Fita, J., Palumbo, E., Pulido, T.H., Guigo, R., and Johnson, R. (2017). LncATLAS database for subcellular localization of long noncoding RNAs. Rna 23, 1080-1087.
Meng, X., Wang, Z., Lou, Q., Rankine, A.N., Zheng, W., Zhang, Z., Zhang, L., and Gu, H. (2021). Long non-coding RNAs in Head and Neck Squamous Cell Carcinoma: Diagnostic biomarkers, Targeted therapies, and Prognostic roles. European Journal of Pharmacology, 174114.
Mercer, T.R., Dinger, M.E., and Mattick, J.S. (2009). Long non-coding RNAs: insights into functions. Nature reviews genetics 10, 155-159.
Miro, C., Di Cicco, E., Ambrosio, R., Mancino, G., Di Girolamo, D., Cicatiello, A.G., Sagliocchi, S., Nappi, A., De Stefano, M.A., and Luongo, C. (2019). Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch. Nature communications 10, 1-13.
Mitobe, Y., Takayama, K., Horie-Inoue, K., and Inoue, S. (2018). Prostate cancer-associated lncRNAs. Cancer letters 418, 159-166.
O’Brien, S.J., Bishop, C., Hallion, J., Fiechter, C., Scheurlen, K., Paas, M., Burton, J., and Galandiuk, S. (2020). Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review. Cancer biology & therapy 21, 769-781.
Paduch, R. (2016). The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cellular Oncology 39, 397-410.
Parasramka, M.A., Maji, S., Matsuda, A., Yan, I.K., and Patel, T. (2016). Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacology & therapeutics 161, 67-78.
Qian, X., Hulit, J., Suyama, K., Eugenin, E., Belbin, T., Loudig, O., Smirnova, T., Zhou, Z., Segall, J., and Locker, J. (2013). p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasis. Oncogene 32, 2292-2303.
Qian, Y., Liu, D., Cao, S., Tao, Y., Wei, D., Li, W., Li, G., Pan, X., and Lei, D. (2017). Upregulation of the long noncoding RNA UCA1 affects the proliferation, invasion, and survival of hypopharyngeal carcinoma. Molecular cancer 16, 1-7.
Rashid, F., Shah, A., and Shan, G. (2016). Long non-coding RNAs in the cytoplasm. Genomics, proteomics & bioinformatics 14, 73-80.
Richards, E.J., Zhang, G., Li, Z., Permuth Wey, J., Challa, S., Li, Y., Kong, W., Dan, S., Bui, M.M., and Coppola, D. (2015). Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia. Journal of Biological Chemistry 290, 6857-6867.
Sanders, O., and Pathak, S. (2021). Hypopharyngeal Cancer. StatPearls.
Saxena, K., Jolly, M.K., and Balamurugan, K. (2020). Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis. Translational oncology 13, 100845.
Schmitt, A.M., and Chang, H.Y. (2016). Long noncoding RNAs in cancer pathways. Cancer cell 29, 452-463.
Slik, K., Blom, S., Turkki, R., Välimäki, K., Kurki, S., Mustonen, H., Haglund, C., Carpén, O., Kallioniemi, O., and Korkeila, E. (2019). Combined epithelial marker analysis of tumour budding in stage II colorectal cancer. The Journal of Pathology: Clinical Research 5, 63-78.
Statello, L., Guo, C., Chen, L., and Huarte, M. (2020). Gene regulation by long non-coding RNAs and its biological functions. Nature reviews Molecular cell biology, 1-23.
Svensson, S., Nilsson, K., Ringberg, A., and Landberg, G. (2003). Invade or proliferate? Two contrasting events in malignant behavior governed by p16INK4a and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer research 63, 1737-1742.
Thiery, J.P., Acloque, H., Huang, R.Y., and Nieto, M.A. (2009). Epithelial-mesenchymal transitions in development and disease. cell 139, 871-890.
Thiery, J.P., and Sleeman, J.P. (2006). Complex networks orchestrate epithelial–mesenchymal transitions. Nature reviews Molecular cell biology 7, 131-142.
Tian, T., Wang, M., Lin, S., Guo, Y., Dai, Z., Liu, K., Yang, P., Dai, C., Zhu, Y., and Zheng, Y. (2018). The impact of lncRNA dysregulation on clinicopathology and survival of breast cancer: a systematic review and meta-analysis. Molecular Therapy-Nucleic Acids 12, 359-369.
Tuo, Y., Li, X., and Luo, J. (2015). Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci 19, 3403-3411.
Tuo, Z., Zhang, J., and Xue, W. (2018). LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Biochemical and biophysical research communications 499, 875-881.
Volovat, S.R., Volovat, C., Hordila, I., Hordila, D.A., Mirestean, C.C., Miron, O.T., Lungulescu, C., Scripcariu, D.V., Stolniceanu, C.R., and Konsoulova-Kirova, A.A. (2020). MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Frontiers in oncology 10.
Wang, F., Ying, H., He, B., Pan, Y., Deng, Q., Sun, H., Chen, J., Liu, X., and Wang, S. (2015). Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 6, 7899.
Wang, H., Guan, Z., He, K., Qian, J., Cao, J., and Teng, L. (2017a). LncRNA UCA1 in anti-cancer drug resistance. Oncotarget 8, 64638.
Wang, J., Li, L., Wu, K., Ge, W., Zhang, Z., Gong, L., and Yuan, D. (2016). Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells. Die Pharmazie-An International Journal of Pharmaceutical Sciences 71, 598-602.
Wang, X., Zhang, Z., Wang, H., Cai, J., Xu, Q., Li, M., Chen, Y., Qian, X., Lu, T., and Yu, L. (2006). Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clinical cancer research 12, 4851-4858.
Wang, Z., Cai, Q., Hu, L., He, C., Li, J., Quan, Z., Liu, B., Li, C., and Zhu, Z. (2017b). Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer. Cell death and disease 8, e2839-e2839.
Wu, J., Li, W., Ning, J., Yu, W., Rao, T., and Cheng, F. (2019). Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition. OncoTargets and therapy 12, 495.
Xia, T., Liao, Q., Jiang, X., Shao, Y., Xiao, B., Xi, Y., and Guo, J. (2014). Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Scientific reports 4, 1-7.
Xie, X., Li, X., Wang, F., and Chen, W. (2010). Cellular localization and tissue expression pattern of UCA1, a non-coding RNA. Journal of Southern Medical University 30, 57-60.
Yan, M., Yang, X., Shen, R., Wu, C., Wang, H., Ye, Q., Yang, P., Zhang, L., Chen, M., and Wan, B. (2018). miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer. Cell death & disease 9, 1-17.
Yang, Q., and Deng, Y. (2014). Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers. International journal of clinical and experimental pathology 7, 1286.
Yao, R.W., Wang, Y., and Chen, L.-L. (2019). Cellular functions of long noncoding RNAs. Nature cell biology 21, 542-551.
Ying, L., Chen, Q., Wang, Y., Zhou, Z., Huang, Y., and Qiu, F. (2012). Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Molecular biosystems 8, 2289-2294.
Zhang, C., Ge, S., Gong, W., Xu, J., Guo, Z., Liu, Z., Gao, X., Wei, X., and Ge, S. (2020). LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype. Cell death and disease 11, 1-13.
Zhang, X., Hong, R., Chen, W., Xu, M., and Wang, L. (2019). The role of long noncoding RNA in major human disease. Bioorganic chemistry 92, 103214.
Zhang, Y., Pitchiaya, S., Cieślik, M., Niknafs, Y.S., Tien, J.C., Hosono, Y., Iyer, M.K., Yazdani, S., Subramaniam, S., and Shukla, S.K. (2018). Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. Nature genetics 50, 814-824.
TCOG下咽癌工作群編撰小組（2015）。《下咽癌臨床診療指引》。臺灣：國家衛生研究